TY - JOUR AU - Majbour, Nour K. AU - Aasly, Jan O. AU - Hustad, Eldbjørg AU - Thomas, Mercy A. AU - Vaikath, Nishant N. AU - Elkum, Naser AU - van de Berg, Wilma D. J. AU - Tokuda, Takahiko AU - Mollenhauer, Brit AU - Berendse, Henk W. AU - El-Agnaf, Omar M. A. PY - 2020 DA - 2020/05/06 TI - CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers JO - Translational Neurodegeneration SP - 15 VL - 9 IS - 1 AB - Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson’s disease (PD). In this study, we aim to identify CSF candidate risk biomarkers of PD in individuals with LRRK2 mutation carriers. SN - 2047-9158 UR - https://doi.org/10.1186/s40035-020-00192-4 DO - 10.1186/s40035-020-00192-4 ID - Majbour2020 ER -